Materias dentro de su búsqueda.
Mostrando 2,241 - 2,260 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.35s Limitar resultados
  1. 2241
    “…This deprived numerous hepatitis C patients with concurrent cardiovascular problems of receiving this highly effective treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Elbasvir/Grazoprevir, an Alternative in Antiviral Hepatitis C Therapy in Patients under Amiodarone Treatment
  2. 2242
    “…Chronic hepatitis C virus (HCV) infection is a leading cause of chronic liver diseases and hepatocellular carcinoma (HCC) worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Host-targeting therapies for hepatitis C virus infection: current developments and future applications
  3. 2243
    “…Background: Hepatitis C virus (HCV) is a hepatotropic, blood-borne virus, but in up to one-third of infections of the transmission route remained unidentified. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body Fluids
  4. 2244
    por Dousson, Cyril B
    Publicado 2018
    “…Sofosbuvir is the first nucleotide prodrug marketed for hepatitis C virus treatment and the backbone of current combination therapies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection
  5. 2245
    por Zhu, Huange, Geng, Yan, He, Qian, Li, Miaoxian
    Publicado 2018
    “…Hepatitis C is one of the most common types of viral hepatitis that impair human health. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    miRNAs regulate immune response and signaling during hepatitis C virus infection
  6. 2246
    “…Hepatitis C virus (HCV), a major causative agent of post transfusion non‐A, non‐B hepatitis (NANBH), can only infect humans and chimpanzees. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Transgenic Mouse Expressing a Full‐length Hepatitis C Virus cDNA
  7. 2247
    “…CONCLUSION: Treatment with SOF + DCV, with or without RBV, results in an improved PRO similar to treatment with SOF + SMV in chronic hepatitis C patients.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C
  8. 2248
    “…For over a decade, the vast majority of new hepatitis C virus (HCV) infections have been among young people who inject drugs (PWID). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Under one roof: identification, evaluation, and treatment of chronic hepatitis C in addiction care
  9. 2249
    “…Hepatitis C virus (HCV)-specific T cell responses are critical for immune control of infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evidence of CD4(+) T cell-mediated immune pressure on the Hepatitis C virus genome
  10. 2250
    “…GOALS: To examine the role that autoantibodies (auto-abs) play in chronic hepatitis C virus (HCV) regarding demographics, presence of extrahepatic manifestations and long-term outcomes in a large US cohort. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations
  11. 2251
    “…PURPOSE OF REVIEW: The landscape of abdominal organ transplantation has been altered by the emergence of curative direct-acting antiviral agents for hepatitis C. Expansion of the thoracic donor pool to include the hearts and the lungs from hepatitis C-positive donors holds promise to increase available donor organs. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The New Direct Antiviral Agents and Hepatitis C in Thoracic Transplantation: Impact on Donors and Recipients
  12. 2252
    “…Hepatitis C virus (HCV) can escape from innate and adaptive immunity, making the immune response ineffective. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Liver HLA-E Expression Is Associated with Severity of Liver Disease in Chronic Hepatitis C
  13. 2253
    “…We report an unusual case of extreme diffuse gallbladder thickening in a 39-year-old lady, subsequently diagnosed with hepatitis C virus, and with complete resolution of her radiological appearances within 6 weeks—before commencing any treatment.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Rapid resolution of extreme gallbladder wall thickening in a patient with acute hepatitis C
  14. 2254
    “…INTRODUCTION: People living with hepatitis C virus (HCV) infection are disproportionately over-represented in the healthcare system due to various individual and contextual circumstances, including comorbidities and socioeconomic marginalisation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C virus infection and hospital-related outcomes: a systematic review protocol
  15. 2255
    “…Hepatitis C virus (HCV) glycoproteins E1 and E2 form a heterodimer to constitute viral envelope proteins, which play an essential role in virus entry. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly
  16. 2256
    “…BACKGROUND: Hepatitis C virus (HCV) treatment regimens (DAAs) are well tolerated, efficacious but costly. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population
  17. 2257
    “…OBJECTIVES: Direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) has excellent cure rates and minimal side effects. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A decentralised, multidisciplinary model of care facilitates treatment of hepatitis C in regional Australia
  18. 2258
    “…OBJECTIVE: To evaluate the prevalence of the co-infection between the human immunodeficiency virus (HIV) and hepatitis C virus (HCV), and the prevalence of factors associated with HCV transmission in a rural Cameroonian community. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence of anti-hepatitis C antibodies and its co-infection with HIV in rural Cameroon
  19. 2259
    “…BACKGROUND AND AIMS: Immunoregulatory cytokines influence the persistence of hepatitis C virus (HCV) chronic infection and the extent of liver damage. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    IL-1α correlates with severity of hepatitis C virus-related liver diseases
  20. 2260
    “…INTRODUCTION: Hepatitis C virus (HCV) infection prevalence is believed to be elevated in Punjab, India; however, state-wide prevalence data are not available. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey
Herramientas de búsqueda: RSS